AUtoimmunity PRofile in INterferon β-1a treated multiple sclerosis patients.: The AUPRIN study:: comparison of 2 different dosage of subcutaneous interferon-β-1a

被引：0
|
作者：
Verdun, E
Ricci, A
Cucci, MA
Barbero, P
Pipieri, A
Clerico, M
Giordano, L
Delfico, L
Tassinari, T
Motti, L
Paciello, M
Reggio, A
Aimo, G
Durelli, L
机构：
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [41] Quality of life in multiple sclerosis:: influence of interferon-β1a (Avonex®) treatment
    Vermersch, P
    de Seze, J
    Delisse, B
    Lamaire, S
    Stojkovic, T
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (05) : 377 - 381
  • [42] The PRISMS study. Interferon-β 1a (Rebif) in intermittent multiple sclerosis [Die PRISMS-studie. Interferon-β 1a (Rebif®) bei schubformiger multipler sklerose]
    Hartung H.-P.
    Flachenecker P.
    Weilbach F.X.
    Rieckmann P.
    Der Nervenarzt, 1999, 70 (2) : 182 - 185
  • [43] Intramuscular interferon-β-1a -: In patients at high risk of developing clinically definite multiple sclerosis
    Asif, M
    Siddiqui, A
    Wellington, K
    CNS DRUGS, 2005, 19 (01) : 55 - 61
  • [44] Should patients with relapsing multiple sclerosis be given a higher dose and frequency of interferon-β1a?
    Fox, RJ
    Rudick, RA
    NATURE CLINICAL PRACTICE NEUROLOGY, 2005, 1 (01): : 16 - 17
  • [45] Should patients with relapsing multiple sclerosis be given a higher dose and frequency of interferon-β1a?
    Robert J Fox
    Richard A Rudick
    Nature Clinical Practice Neurology, 2005, 1 : 16 - 17
  • [46] Intramuscular interferon-β-1a: In patients at high risk of developing clinically definite multiple sclerosis
    Siddiqui M.A.A.
    Wellington K.
    CNS Drugs, 2005, 19 (1) : 55 - 61
  • [47] Interferon-β-1a/interferon-β-1bThrombotic microangiopathy: 2 case reports
    Reactions Weekly, 2014, 1509 (1) : 20 - 20
  • [48] Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
    Lorena Lorefice
    Federica Murgia
    Giuseppe Fenu
    Jessica Frau
    Giancarlo Coghe
    Maria Rita Murru
    Stefania Tranquilli
    Andrea Visconti
    Maria Giovanna Marrosu
    Luigi Atzori
    Eleonora Cocco
    Neurotherapeutics, 2019, 16 : 797 - 807
  • [49] ASA Study -: combination of interferon-β 1a, azathioprine and oral prednisone in remitting multiple sclerosis
    Horakova, D
    Havrdova, E
    Krasensky, J
    Meluzinova, E
    Dolezal, O
    Vaneckova, M
    Seidl, Z
    Svobodnik, A
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S262 - S263
  • [50] Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
    Lorefice, Lorena
    Murgia, Federica
    Fenu, Giuseppe
    Frau, Jessica
    Coghe, Giancarlo
    Murru, Maria Rita
    Tranquilli, Stefania
    Visconti, Andrea
    Marrosu, Maria Giovanna
    Atzori, Luigi
    Cocco, Eleonora
    NEUROTHERAPEUTICS, 2019, 16 (03) : 797 - 807
12345